Delivery Order SPE2D018D0005-SPE2D325F2111

Award Date 11/20/24
Potential Completion Date 11/25/24
Potential Value $1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2D018D0005
    Indefinite Delivery Contract
  • SPE2D018D0005-SPE2D325F2111
    Delivery Order

This federal contract award is for the delivery of "REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL" to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract was awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, on November 20, 2024 with a ceiling value of $1,037.23. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 25, 2024. The contract does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone Joint Venture and Manufacturer of Goods, and has provided various medical equipment, reagents, and testing services to federal agencies including the Department of Veterans Affairs, Defense Health Agency, and Department of Health and Human Services.

Generated 2/19/25, 9:12 AM